IL138951A0 - Controlled release peroral compositions of levosimendan - Google Patents

Controlled release peroral compositions of levosimendan

Info

Publication number: IL138951A0
Authority: IL; Israel
Prior art keywords: levosimendan; controlled release; peroral compositions; release peroral; compositions
Prior art date: 1998-04-23

Application number

IL13895199A

Other languages

English (en)

Original Assignee

Orion Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-04-23

Filing date

1999-04-23

Publication date

2001-11-25

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8551575&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL138951(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1999-04-23 Application filed by Orion Corp filed Critical Orion Corp

2001-11-25 Publication of IL138951A0 publication Critical patent/IL138951A0/xx

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/50—Pyridazines; Hydrogenated pyridazines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
Public Health (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Epidemiology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Cardiology (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Heart & Thoracic Surgery (AREA)
Urology & Nephrology (AREA)
Vascular Medicine (AREA)
Hospice & Palliative Care (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Agricultural Chemicals And Associated Chemicals (AREA)
Detergent Compositions (AREA)
Cosmetics (AREA)

IL13895199A 1998-04-23 1999-04-23 Controlled release peroral compositions of levosimendan IL138951A0 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
FI980901A FI980901A (sv)	1998-04-23	1998-04-23	Orala sammansättningar som kontrollerat frigör levosimendan
PCT/FI1999/000329 WO1999055305A2 (en)	1998-04-23	1999-04-23	Controlled release peroral compositions of levosimendan

Publications (1)

Publication Number	Publication Date
IL138951A0 true IL138951A0 (en)	2001-11-25

Family

ID=8551575

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
IL13895199A IL138951A0 (en)	1998-04-23	1999-04-23	Controlled release peroral compositions of levosimendan
IL138951A IL138951A (en)	1998-04-23	2000-10-11	Controlled release of Froel Malbusmandan

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
IL138951A IL138951A (en)	1998-04-23	2000-10-11	Controlled release of Froel Malbusmandan

Country Status (38)

Country	Link
US (1)	US7045147B1 (sv)
EP (1)	EP1071397B1 (sv)
JP (2)	JP4566402B2 (sv)
KR (1)	KR100960597B1 (sv)
CN (1)	CN1248691C (sv)
AR (1)	AR019096A1 (sv)
AT (1)	ATE258425T1 (sv)
AU (1)	AU756641B2 (sv)
BG (1)	BG64839B1 (sv)
BR (1)	BR9909869A (sv)
CA (1)	CA2329234C (sv)
CO (1)	CO5070607A1 (sv)
CZ (1)	CZ295194B6 (sv)
DE (1)	DE69914472T2 (sv)
DK (1)	DK1071397T3 (sv)
EA (1)	EA002829B1 (sv)
EE (1)	EE04220B1 (sv)
ES (1)	ES2215379T3 (sv)
FI (1)	FI980901A (sv)
GE (1)	GEP20032906B (sv)
HK (1)	HK1034032A1 (sv)
HR (1)	HRP20000704B1 (sv)
HU (1)	HUP0101458A3 (sv)
ID (1)	ID27987A (sv)
IL (2)	IL138951A0 (sv)
MX (1)	MXPA00010367A (sv)
NO (1)	NO329809B1 (sv)
NZ (1)	NZ507453A (sv)
PL (1)	PL197447B1 (sv)
PT (1)	PT1071397E (sv)
RS (1)	RS49962B (sv)
SI (1)	SI1071397T1 (sv)
SK (1)	SK285427B6 (sv)
TR (1)	TR200003102T2 (sv)
TW (1)	TWI224507B (sv)
UA (1)	UA68376C2 (sv)
WO (1)	WO1999055305A2 (sv)
ZA (1)	ZA200005632B (sv)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FI20011465A0 (sv) *	2001-07-04	2001-07-04	Orion Corp	Ny användning av en pyridazinonderivat
MXPA05009886A (es) *	2003-03-14	2006-05-04	Nirmal Mulye	Un proceso para preparar tabletas de liberacion constante.
FI20070521L (sv) *	2006-11-10	2008-05-11	Atacama Labs Oy	Korn, tabletter och granuleringsförfarande
AU2009267052B2 (en)	2008-06-30	2013-07-11	Tocagen Inc.	Formulations of 5-fluorocytosine and uses thereof
JP2014172850A (ja) *	2013-03-07	2014-09-22	Capsugel Belgium Nv	ハードカプセル製剤
CN105784895B (zh) *	2015-10-30	2018-05-22	成都欣捷高新技术开发有限公司	一种用高效液相色谱仪检测左西孟旦中杂质的方法
JP2023507626A (ja)	2019-12-16	2023-02-24	テナックス・セラピューティクス，インコーポレイテッド	駆出率が保たれた心不全を伴う肺高血圧症（ＰＨ－ＨＦ－ｐＥＦ）を治療するためのレボシメンダン

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
PT76448B (en)	1982-04-05	1986-03-20	Merck Sharp & Dohme	Process for preparing stabilization of unstable drugs or food supplements containing antibiotics mainly ephrotomycin
US4716042A (en)	1986-06-16	1987-12-29	American Home Products Corporation	Stabilized coated aspirin tablets
GB8903130D0 (en)	1989-02-11	1989-03-30	Orion Yhtymae Oy	Substituted pyridazinones
GB2251615B (en) *	1991-01-03	1995-02-08	Orion Yhtymae Oy	(-)-[[4-(1,4,5,6-tetrahydro-4-methyl-6-oxo-3-pyridazinyl)phenyl]hydrazono]pro panedinitrile
US5213811A (en) *	1991-09-13	1993-05-25	Sterling Drug Inc.	Oral sustained-release drug compositions
GB2266841A (en) *	1992-05-06	1993-11-17	Orion Yhtymae Oy	Compounds for use as anti-ischemic medicaments
US5795909A (en) *	1996-05-22	1998-08-18	Neuromedica, Inc.	DHA-pharmaceutical agent conjugates of taxanes
GB9614098D0 (en)	1996-07-05	1996-09-04	Orion Yhtymae Oy	Transdermal delivery of levosimendan
FI973804A (sv) *	1997-09-26	1999-03-27	Orion Yhtymae Oy	Orala sammansättningar av levosimendan
FI974578A (sv) *	1997-12-19	1999-06-20	Orion Yhtymae Oyj	Förfarande för givande av levosimendan
FI980902A (sv) *	1998-04-23	1999-10-24	Orion Yhtymae Oyj	Stabila sammansättningar av levosimendan

1998
- 1998-04-23 FI FI980901A patent/FI980901A/sv unknown
1999
- 1999-03-26 CO CO99018533A patent/CO5070607A1/es unknown
- 1999-04-09 TW TW088105661A patent/TWI224507B/zh not_active IP Right Cessation
- 1999-04-22 AR ARP990101869A patent/AR019096A1/es active IP Right Grant
- 1999-04-23 TR TR2000/03102T patent/TR200003102T2/xx unknown
- 1999-04-23 BR BR9909869-5A patent/BR9909869A/pt not_active Application Discontinuation
- 1999-04-23 MX MXPA00010367A patent/MXPA00010367A/es unknown
- 1999-04-23 RS YUP-639/00A patent/RS49962B/sr unknown
- 1999-04-23 GE GEAP19995639A patent/GEP20032906B/en unknown
- 1999-04-23 CZ CZ20003780A patent/CZ295194B6/cs not_active IP Right Cessation
- 1999-04-23 UA UA2000116616A patent/UA68376C2/uk unknown
- 1999-04-23 PL PL344078A patent/PL197447B1/pl not_active IP Right Cessation
- 1999-04-23 HU HU0101458A patent/HUP0101458A3/hu unknown
- 1999-04-23 WO PCT/FI1999/000329 patent/WO1999055305A2/en not_active Application Discontinuation
- 1999-04-23 NZ NZ507453A patent/NZ507453A/xx unknown
- 1999-04-23 EE EEP200000617A patent/EE04220B1/xx not_active IP Right Cessation
- 1999-04-23 US US09/673,794 patent/US7045147B1/en not_active Expired - Fee Related
- 1999-04-23 IL IL13895199A patent/IL138951A0/xx active IP Right Grant
- 1999-04-23 SI SI9930536T patent/SI1071397T1/xx unknown
- 1999-04-23 DE DE69914472T patent/DE69914472T2/de not_active Expired - Lifetime
- 1999-04-23 JP JP2000545505A patent/JP4566402B2/ja not_active Expired - Fee Related
- 1999-04-23 DK DK99916941T patent/DK1071397T3/da active
- 1999-04-23 KR KR1020007011788A patent/KR100960597B1/ko not_active IP Right Cessation
- 1999-04-23 CN CNB998064181A patent/CN1248691C/zh not_active Expired - Fee Related
- 1999-04-23 EP EP99916941A patent/EP1071397B1/en not_active Expired - Lifetime
- 1999-04-23 AT AT99916941T patent/ATE258425T1/de not_active IP Right Cessation
- 1999-04-23 SK SK1554-2000A patent/SK285427B6/sk not_active IP Right Cessation
- 1999-04-23 ES ES99916941T patent/ES2215379T3/es not_active Expired - Lifetime
- 1999-04-23 PT PT99916941T patent/PT1071397E/pt unknown
- 1999-04-23 CA CA002329234A patent/CA2329234C/en not_active Expired - Fee Related
- 1999-04-23 AU AU35246/99A patent/AU756641B2/en not_active Ceased
- 1999-04-23 EA EA200001098A patent/EA002829B1/ru not_active IP Right Cessation
- 1999-04-23 ID IDW20002367A patent/ID27987A/id unknown
2000
- 2000-10-11 IL IL138951A patent/IL138951A/en not_active IP Right Cessation
- 2000-10-12 ZA ZA200005632A patent/ZA200005632B/en unknown
- 2000-10-19 HR HR20000704A patent/HRP20000704B1/xx not_active IP Right Cessation
- 2000-10-20 NO NO20005313A patent/NO329809B1/no not_active IP Right Cessation
- 2000-11-17 BG BG104959A patent/BG64839B1/bg unknown
2001
- 2001-02-14 HK HK01101050A patent/HK1034032A1/xx not_active IP Right Cessation
2010
- 2010-01-12 JP JP2010004367A patent/JP2010083900A/ja not_active Withdrawn

Also Published As

Publication number	Publication date
SK15542000A3 (sk)	2001-08-06
US7045147B1 (en)	2006-05-16
PL197447B1 (pl)	2008-03-31
HRP20000704B1 (en)	2009-11-30
CN1301163A (zh)	2001-06-27
CA2329234C (en)	2008-06-10
SK285427B6 (sk)	2007-01-04
BR9909869A (pt)	2000-12-19
FI980901A (sv)	1999-10-24
TWI224507B (en)	2004-12-01
EE200000617A (et)	2002-06-17
WO1999055305A2 (en)	1999-11-04
DK1071397T3 (da)	2004-04-05
NZ507453A (en)	2003-02-28
HUP0101458A3 (en)	2002-05-28
KR100960597B1 (ko)	2010-06-07
IL138951A (en)	2006-10-31
PT1071397E (pt)	2004-06-30
CZ295194B6 (cs)	2005-06-15
BG64839B1 (bg)	2006-06-30
EP1071397A2 (en)	2001-01-31
EA002829B1 (ru)	2002-10-31
ATE258425T1 (de)	2004-02-15
HRP20000704A2 (en)	2001-04-30
EA200001098A1 (ru)	2001-04-23
SI1071397T1 (en)	2004-06-30
JP2010083900A (ja)	2010-04-15
NO20005313D0 (no)	2000-10-20
CA2329234A1 (en)	1999-11-04
AR019096A1 (es)	2001-12-26
GEP20032906B (en)	2003-02-25
MXPA00010367A (es)	2002-06-04
JP4566402B2 (ja)	2010-10-20
KR20010071172A (ko)	2001-07-28
YU63900A (sh)	2003-07-07
AU756641B2 (en)	2003-01-16
AU3524699A (en)	1999-11-16
DE69914472T2 (de)	2004-11-11
FI980901A0 (sv)	1998-04-23
CZ20003780A3 (en)	2001-05-16
EE04220B1 (et)	2004-02-16
ES2215379T3 (es)	2004-10-01
BG104959A (en)	2001-07-31
CO5070607A1 (es)	2001-08-28
DE69914472D1 (de)	2004-03-04
ZA200005632B (en)	2002-01-14
PL344078A1 (en)	2001-09-24
TR200003102T2 (tr)	2001-02-21
HK1034032A1 (en)	2001-10-12
CN1248691C (zh)	2006-04-05
RS49962B (sr)	2008-09-29
NO20005313L (no)	2000-11-21
JP2002512946A (ja)	2002-05-08
EP1071397B1 (en)	2004-01-28
WO1999055305A3 (en)	1999-12-29
HUP0101458A2 (hu)	2002-03-28
UA68376C2 (en)	2004-08-16
NO329809B1 (no)	2010-12-20
ID27987A (id)	2001-05-03

Publication	Publication Date	Title
SG93831A1 (en)	2003-01-21	Polimeric controlled release compositions
SG71879A1 (en)	2000-04-18	Controlled release compositions
HK1043062A1 (en)	2002-09-06	Controlled release galantamine composition
PL331983A1 (en)	1999-09-27	Solid deodorising composition
IL211075A0 (en)	2011-04-28	Multiparticulate modified release composition
SG71789A1 (en)	2000-04-18	Controlled release compositions
HK1010494A1 (en)	1999-06-25	Paroxetine controlled release compositions
IL134802A0 (en)	2001-04-30	Oral compositions of levosimendan
SG72947A1 (en)	2000-05-23	Controlled release compositions
PL334234A1 (en)	2000-02-14	Antiperspirant or deodorising compositions
IL138951A0 (en)	2001-11-25	Controlled release peroral compositions of levosimendan
AU4917499A (en)	2000-01-24	Refractory compositions
GC0000104A (en)	2005-06-29	Controlled release peroral compositions of levosimendan.
GB9614188D0 (en)	1996-09-04	Ceramic compositions
GB2325222B (en)	2000-09-27	Refractory compositions
GB9828654D0 (en)	1999-02-17	Release coating composition
GB2342044B (en)	2002-02-13	Quick release compositions
GB9609651D0 (en)	1996-07-10	Refractory compositions
GB9816563D0 (en)	1998-09-30	Controlled release formulations
GB9813232D0 (en)	1998-08-19	Perfume compositions

Legal Events

Date	Code	Title
2007-06-17	FF	Patent granted
2007-07-06	KB	Patent renewed
2009-11-18	KB	Patent renewed